kellygirskis

Kelly Girskis | President

Kelly is a PhD student in the Program of Neuroscience at Harvard. Her thesis work in Dr. Christopher Walsh's lab focuses on how evolutionary changes in the human genome contribute to species-specific gene regulation and corticogenesis.

LinkedIn

IMG_1437 2.JPG

Soufiane Aboulhouda | President

Soufiane is a PhD student in the Biological and Biomedical Sciences program at Harvard. His research in the lab of Dr. George Church at the Wyss Institute is focused on genome engineering and cell therapies.

soufiane_ab@g.harvard.edu  

Emily Cohen | Vice President

Senior Director of Programming

Emily is a postdoc in the Pathology Department at Beth Israel Deaconess Medical Center. In the laboratory of Dr. Alex Toker, she is investigating the mechanism of resistance to therapeutic inhibitors in breast cancer.

LinkedIn

Screen Shot 2017-06-27 at 3.17.45 PM.png

Rebecca Gibbs

Director of the Life Science Innovation Program (LSIP)

Becca is a PhD student in the Biological and Biomedical Sciences program at Harvard. Her thesis work in the lab of Dr. Lee Rubin focuses on leveraging the regenerative potential of stem cells to develop novel treatments for muscle disorders.

LinkedIn

 
  Radwa Sharaf    Director of Site Visits   Radwa is a PhD candidate at Havard Medical School, working in the Infectious Diseases Division at Brigham and Women's Hospital. Her work focuses on mechanisms of HIV-1 control in a rare group of patients. In addition to bench work, she is interested in how host and pathogen sequences dictate phenotypes and cellular behavior.  LinkedIn      

Radwa Sharaf

Director of Site Visits

Radwa is a PhD candidate at Havard Medical School, working in the Infectious Diseases Division at Brigham and Women's Hospital. Her work focuses on mechanisms of HIV-1 control in a rare group of patients. In addition to bench work, she is interested in how host and pathogen sequences dictate phenotypes and cellular behavior. LinkedIn     

  Stephanie Fischinger, Programming Team    Stephanie is a PhD student from Germany working in the lab of Dr Galit Alter at the Ragon Institute of MGH, MIT and Harvard in Cambridge. Her research focuses on the effects of priming and boosting in HIV vaccine trials on antibody properties in order to dissect the optimal profile for a preventive HIV vaccine.

Stephanie Fischinger, Programming Team

Stephanie is a PhD student from Germany working in the lab of Dr Galit Alter at the Ragon Institute of MGH, MIT and Harvard in Cambridge. Her research focuses on the effects of priming and boosting in HIV vaccine trials on antibody properties in order to dissect the optimal profile for a preventive HIV vaccine.

  Joseph Mandelbaum, Programming Team   Joseph is a PhD student in the Biological and Biomedical Sciences program at Harvard. His thesis work in the lab of Dr. Leonard Zon focuses on chemical screening for modulators of hematopoietic stem cell expansion using zebrafish embryo cultures.         

Joseph Mandelbaum, Programming Team

Joseph is a PhD student in the Biological and Biomedical Sciences program at Harvard. His thesis work in the lab of Dr. Leonard Zon focuses on chemical screening for modulators of hematopoietic stem cell expansion using zebrafish embryo cultures.

 

 

 

jeff_headshot

Jeff Haswell

Director of Harvard Biotech Incubator (HBI)

Jeff is a PhD student in the Biological and Biomedical Sciences Program at Harvard. His thesis work in Dr. Frank Slack’s lab focuses on developing CRISPR and TALEN gene editing techniques to target both coding and non-coding RNAs in human embryonic stem cells.  

 
  Lin Ao    Director of Patent Law Course    Lin is a postdoctoral research fellow in the Department of Cancer Immunology and Virology at Dana-Farber Cancer Institute. Her current work in the lab of Dr. Harvey Cantor focuses on the discovery of novel genetic targets in the tumor immune microenvironment.    www.linkedin.com/in/linao5589

Lin Ao

Director of Patent Law Course

Lin is a postdoctoral research fellow in the Department of Cancer Immunology and Virology at Dana-Farber Cancer Institute. Her current work in the lab of Dr. Harvey Cantor focuses on the discovery of novel genetic targets in the tumor immune microenvironment. 

www.linkedin.com/in/linao5589

  Heather Landry, Programming Team   Heather Landry is a PhD student in the Genetics department at Harvard Medical School. The goal of her thesis research in Dr. Stirling Churchman’s lab is to better understand the molecular dynamics of transcription and splicing in human cells.

Heather Landry, Programming Team

Heather Landry is a PhD student in the Genetics department at Harvard Medical School. The goal of her thesis research in Dr. Stirling Churchman’s lab is to better understand the molecular dynamics of transcription and splicing in human cells.

  Jonathan Portman, Programming Team   Jon is a postdoctoral research fellow in the Department of Microbiology and Immunobiology at Harvard Medical School. After gaining significant experience in bacterial genetics and physiology from his thesis work with Dr. Daniel Portnoy at UC Berkeley, he is now in the lab of Dr. Michael Starnbach developing modern molecular tools in the genetically recalcitrant  C. trachomatis  as a strategy to better probe the host's T-cell response to chronic infections.  LinkedIn

Jonathan Portman, Programming Team

Jon is a postdoctoral research fellow in the Department of Microbiology and Immunobiology at Harvard Medical School. After gaining significant experience in bacterial genetics and physiology from his thesis work with Dr. Daniel Portnoy at UC Berkeley, he is now in the lab of Dr. Michael Starnbach developing modern molecular tools in the genetically recalcitrant C. trachomatis as a strategy to better probe the host's T-cell response to chronic infections. LinkedIn

IMG_4327.JPG

Hannah Goldberg

Director of Healthcare Innovation and Commercialization (HIC) Course

Hannah is a PhD student in the Harvard/MIT Speech Hearing Bioscience and Technology program. In 2016 she was accepted into Harvard's Therapeutics Graduate Program to further focus on pharmacology, toxicology and drug discovery. Her concentration in translational
science has brought her to the Holt/Géléoc Lab to explore the effectiveness of gene therapy as an approach to restore auditory functioning in models of human deafness.                                                                             

  Ali Rudolph, Communications Team   Ali is a Ph.D student in the Biological and Biomedical Sciences program at Harvard University. She is a member of the team developing a strain of  Escherichia coli  with a 57-codon genome in George Church’s lab.

Ali Rudolph, Communications Team

Ali is a Ph.D student in the Biological and Biomedical Sciences program at Harvard University. She is a member of the team developing a strain of Escherichia coli with a 57-codon genome in George Church’s lab.

 
  Fadi Najm, Programming Team   Fadi is a PhD student in the Biological and Biomedical Sciences Program at Harvard. His thesis work in the laboratory of Bradley Bernstein is centered on identifying and unraveling complex cancer dependencies. He holds an MBA from Case Western Reserve University and his previous patents and publications have recently resulted in the start-up of Convelo Therapeutics.   Linkedin

Fadi Najm, Programming Team

Fadi is a PhD student in the Biological and Biomedical Sciences Program at Harvard. His thesis work in the laboratory of Bradley Bernstein is centered on identifying and unraveling complex cancer dependencies. He holds an MBA from Case Western Reserve University and his previous patents and publications have recently resulted in the start-up of Convelo Therapeutics.  Linkedin